Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Pharmacological characterization of FE 202158, a novel, potent, selective, and short-acting peptidic vasopressin V1a receptor full agonist for the treatment of vasodilatory hypotension.

Laporte R, Kohan A, Heitzmann J, Wisniewska H, Toy J, La E, Tariga H, Alagarsamy S, Ly B, Dykert J, Qi S, Wisniewski K, Galyean R, Croston G, Schteingart CD, Rivière PJ.

J Pharmacol Exp Ther. 2011 Jun;337(3):786-96. doi: 10.1124/jpet.111.178848. Epub 2011 Mar 16.

2.

A uniquely selective inhibitor of the mammalian fetal neuromuscular nicotinic acetylcholine receptor.

Teichert RW, Rivier J, Torres J, Dykert J, Miller C, Olivera BM.

J Neurosci. 2005 Jan 19;25(3):732-6.

3.

AlphaA-Conotoxin OIVA defines a new alphaA-conotoxin subfamily of nicotinic acetylcholine receptor inhibitors.

Teichert RW, Rivier J, Dykert J, Cervini L, Gulyas J, Bulaj G, Ellison M, Olivera BM.

Toxicon. 2004 Aug;44(2):207-14.

PMID:
15246771
4.

GnRH antagonists: a new generation of long acting analogues incorporating p-ureido-phenylalanines at positions 5 and 6.

Jiang G, Stalewski J, Galyean R, Dykert J, Schteingart C, Broqua P, Aebi A, Aubert ML, Semple G, Robson P, Akinsanya K, Haigh R, Riviere P, Trojnar J, Junien JL, Rivier JE.

J Med Chem. 2001 Feb 1;44(3):453-67.

PMID:
11462984
5.

Contulakin-G, an O-glycosylated invertebrate neurotensin.

Craig AG, Norberg T, Griffin D, Hoeger C, Akhtar M, Schmidt K, Low W, Dykert J, Richelson E, Navarro V, Mazella J, Watkins M, Hillyard D, Imperial J, Cruz LJ, Olivera BM.

J Biol Chem. 1999 May 14;274(20):13752-9.

6.

An O-glycosylated neuroexcitatory conus peptide.

Craig AG, Zafaralla G, Cruz LJ, Santos AD, Hillyard DR, Dykert J, Rivier JE, Gray WR, Imperial J, DelaCruz RG, Sporning A, Terlau H, West PJ, Yoshikami D, Olivera BM.

Biochemistry. 1998 Nov 17;37(46):16019-25.

PMID:
9819194
7.

A novel post-translational modification involving bromination of tryptophan. Identification of the residue, L-6-bromotryptophan, in peptides from Conus imperialis and Conus radiatus venom.

Craig AG, Jimenez EC, Dykert J, Nielsen DB, Gulyas J, Abogadie FC, Porter J, Rivier JE, Cruz LJ, Olivera BM, McIntosh JM.

J Biol Chem. 1997 Feb 21;272(8):4689-98.

8.

A new family of Conus peptides targeted to the nicotinic acetylcholine receptor.

Hopkins C, Grilley M, Miller C, Shon KJ, Cruz LJ, Gray WR, Dykert J, Rivier J, Yoshikami D, Olivera BM.

J Biol Chem. 1995 Sep 22;270(38):22361-7.

9.

Rat corticostatin R4: synthesis, disulfide bridge assignment, and in vivo activity.

Cervini LA, Gray WR, Kaiser R, Dykert J, Chan R, Solomon S, Rivier CL, Rivier JE.

Peptides. 1995;16(5):837-42.

PMID:
7479324
10.

Isolation of Lys-conopressin-G from the venom of the worm-hunting snail, Conus imperialis.

Nielsen DB, Dykert J, Rivier JE, McIntosh JM.

Toxicon. 1994 Jul;32(7):845-8.

PMID:
7940591
11.

Gonadotropin-releasing hormone antagonists with N omega-triazolylornithine, -lysine, or -p-aminophenylalanine residues at positions 5 and 6.

Rivier J, Porter J, Hoeger C, Theobald P, Craig AG, Dykert J, Corrigan A, Perrin M, Hook WA, Siraganian RP, et al.

J Med Chem. 1992 Nov 13;35(23):4270-8.

PMID:
1280300
12.

Solid phase synthesis and characterization of two canine gut gastrin-releasing peptides.

Milton RC, Mayer E, Walsh JH, Rivier JE, Dykert J, Lee TD, Shively JE, Reeve JR Jr.

Int J Pept Protein Res. 1988 Aug;32(2):141-52.

PMID:
3220660
13.

Synthesis, resolution and characterization of ring substituted phenylalanines and tryptophans.

Porter J, Dykert J, Rivier J.

Int J Pept Protein Res. 1987 Jul;30(1):13-21.

PMID:
3667074

Supplemental Content

Loading ...
Support Center